Ahead of its move into new space on the fifth floor of the Critical Care Tower in February, the Vanderbilt Heart and Vascular Institute has announced two key position changes.
Michele Hasselblad MSN, R.N., longtime administrative director of the adult cardiac catheterization lab, electrophysiology labs (EP) and director of operative services, has been named the administrative director of inpatient medicine and inpatient VHVI, a position she has held on an interim basis since June 2013. She will retain her director responsibilities in the OR, but will relinquish her role in the cath and EP labs.
“What excites me about this role is the opportunity to support the staff at the bedside and the many wonderful leaders we have at Vanderbilt as we navigate together toward the future,” Hasselblad said. “I have already been so very impressed with the innovative ideas for how to accomplish work in different ways, as well as the identification of opportunities to redesign system issues that impact our caregivers’ daily workflow and ultimately patient care.”
Hasselblad received her ASN in Rochester, Minn., her BSN at Jacksonville University in Jacksonville, Fla., and her MSN at Vanderbilt University in 2010. She has prior experience in procedural operations at the Mayo Clinic and at Vanderbilt.
“An extraordinary leader, Michele has demonstrated skill at building highly competent, engaged teams, inspiring others to high performance standards, accomplishing high levels of service satisfaction for patients and families and improvement in fiscal performance in the areas she has led,” said Robin Steaban, RN., chief administrative officer for VHVI.
“Michele is the co-chair of the Nursing Wellness Program, active in the CMS Valve Bundle Initiative and several professional organizations. We are thankful for Michele’s many contributions to the organization to date and look forward to all she will accomplish with the teams and leaders she will be engaged with going forward.”
Dana Wilson R.N., BSN, MBA, has assumed the role of director of the adult cardiac catheterization labs and the EP labs as well as the cardiac observation unit.
He has been acting in the interim director role and has been the manager of the labs since 2009.
“Dana is a strong staff and physician advocate, and has created an environment of highly satisfied work teams. He has been instrumental in leading VHVI in establishing systems and processes of high reliability, improving the financial performance of the labs through supply chain changes in partnership with physician and supply chain leaders,” Steaban said. “Dana will be leading VHVI interventional services to the move to new facilities in January 2014. We are delighted to have Dana in this leadership role and that he has agreed to advance his career at Vanderbilt.”
Wilson was recruited to Vanderbilt to be the manager of the cath and EP labs after clinical experience in Florida Hospital Orlando and cath lab leadership experience at Orlando Regional Medical Center.
“In the short term, I am hoping to achieve a smooth transition of operations to the new area on the fifth floor of the Critical Care Tower. A second priority is implementing increased collaboration with having electrophysiology, cath lab and holding rooms in one place while improving workflow enhancements to provide improved quality of care and efficiency for the patient experience,” Wilson said.
